CFS
WST icon

CRA Financial Services’s West Pharmaceutical WST Stock Holding History

CRA Financial Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-514
Closed -$241K – 219
2021
Q4 		$241K Hold
514
– – 0.07% 184
2021
Q3 		$218K Buy
+514
New +$217K 0.07% 181
2020
Q4 		– Sell
-734
Closed -$202K – 166
2020
Q3 		$202K Buy
+734
New +$194K 0.1% 137

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

CRA Financial Services's WST Position: Q1 2022 in Review

CRA Financial Services sold out of West Pharmaceutical (WST) in Q1 2022, closing a stake of 514 shares — an estimated $241K sold.

CRA Financial Services first reported a position in WST in Q3 2020 and held it in 3 quarters. The position peaked at $241K in Q4 2021. 717 funds tracked by Wall St. Rank hold WST as of Q1 2022.

  • CRA Financial Services reported no remaining West Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • CRA Financial Services sold 514 West Pharmaceutical shares in Q1 2022, an estimated $241K.
  • CRA Financial Services first reported a position in West Pharmaceutical in Q3 2020 and held it in 3 quarters.
  • CRA Financial Services's West Pharmaceutical position peaked at $241K in Q4 2021.
  • 717 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.

Based on CRA Financial Services's 13F filing for Q1 2022, filed 15 Apr 2022.